Ensayos clínicos de Asma en Texas
20 estudios sobre Asma buscan participantes en Texas.
Ciudades en Texas
- Dallas10 estudios
- Houston8 estudios
- San Antonio6 estudios
- Austin5 estudios
- McKinney5 estudios
- El Paso4 estudios
- Sugar Land3 estudios
- Cypress3 estudios
- The Woodlands3 estudios
Texto oficial del estudio (inglés)
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Austin
- Research Site, Boerne
- Research Site, Dallas
- y 6 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06932263A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Cypress
- GSK Investigational Site, Tomball
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07645248ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, McKinney
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 24 sept 2026 · NCT07301255A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Research Site 17, San Antonio
- Research Site 07, Sugar Land
ReclutandoFase 3
Edades de 12 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07359846A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Horizon Clinical Research Group, Cypress
- Alina Clinical Trials, LLC., Dallas
- y 2 más
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06977581A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Research Site, Dallas
- Research Site, Houston
- Research Site, San Antonio
ReclutandoFase 3
Edades de 5 a 11 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06023589A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 24, Amarillo
- Research Site 19, Baytown
- Research Site 07, Dallas
- y 6 más
ReclutandoFase 3
Edades de 12 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07276724A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Dallas
- GSK Investigational Site, Kerrville
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 9 sept 2026 · NCT05757102A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12083, Austin
- Teva Investigational Site 12060, Austin
- Teva Investigational Site 12179, Cypress
- y 13 más
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 31 ago 2026 · NCT06664619A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Lewisville
- Research Site, San Antonio
ReclutandoFase 2
Edades de 4 a 11 · Todos los sexos · Actualizado el 27 ago 2026 · NCT07525375A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, San Antonio
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Austin
- Research Site, Baytown
- Research Site, Beaumont
- y 12 más
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 13 ago 2026 · NCT06307665A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283
- GSK Investigational Site, Austin
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 60 · Todos los sexos · Actualizado el 29 jul 2026 · NCT07712393A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Dallas
- Research site, Houston
- Research site, San Antonio
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07532265Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
- Orion Clinical Research, Austin
- Pharmaceutical Research & Consulting, Inc., Dallas
- Western Sky Medical Research, El Paso
ReclutandoEstudio observacional
Edades de 5 a 100 · Todos los sexos · Actualizado el 2 jun 2026 · NCT07228026Escitalopram in Asthma Patients With Frequent Exacerbation
- UT Southwestern, 1440 Empire Central, Ste. LD4.100, Dallas
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 ene 2026 · NCT06216535Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Baylor College of Medicine, Houston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 ene 2026 · NCT06273072Individualizing Treatment for Asthma in Primary Care (Full Study)
- JPS Health Network, Fort Worth
- Kelsey Research Foundation, Houston
ReclutandoFase 4
Edades de 13 a 75 · Todos los sexos · Actualizado el 29 oct 2025 · NCT07052942Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
- University of Texas at Arlington, Arlington
- Rebuilding Together North Texas, Plano
Reclutando
Edades de 5 en adelante · Todos los sexos · Actualizado el 29 oct 2025 · NCT07196436Viral Mucosal Reprogramming
- University of Texas Medical Branch, Galveston
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 18 a 60 · Todos los sexos · Actualizado el 28 ene 2025 · NCT05331170De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.